The burden of cancer among people living with HIV in Ontario, Canada, 1997–2020: a retrospective population-based cohort study using administrative health data
Authors:
- Ioana A. NicolauINIoana A. Nicolau
- Tony AntoniouTATony Antoniou
- Jennifer D. BrooksJBJennifer D. Brooks
- Rahim MoineddinRMRahim Moineddin
- Curtis CooperCCCurtis Cooper
- Michelle CotterchioMCMichelle Cotterchio
- Jennifer L. GillisJGJennifer L. Gillis
- Claire E. KendallCKClaire E. Kendall
- Abigail E. KrochAKAbigail E. Kroch
- Joanne D. LindsayJLJoanne D. Lindsay
- Colleen PriceCPColleen Price
- Kate SaltersKSKate Salters
Open Access
- 19 July 2022
- journal article
- research article
- Published by CMA Impact Inc. in CMAJ Open
- Vol. 10 (3) , E666-E674
Abstract
Background: With combination antiretroviral therapy (ART) and increased longevity, cancer is a leading cause of morbidity among people with HIV. We characterized trends in cancer burden among people with HIV in Ontario, Canada, between 1997 and 2020. Methods: We conducted a population-based, retrospective cohort study of adults with HIV using linked administrative health databases from Jan. 1, 1997, to Nov. 1, 2020. We grouped cancers as infection-related AIDS-defining cancers (ADCs), infection-related non-ADCs (NADCs) and infection-unrelated cancers. We calculated age-standardized incidence rates per 100 000 person-years with 95% confidence intervals (CIs) using direct standardization, stratified by calendar period and sex. We also calculated limited-duration prevalence. Results: Among 19 403 adults living with HIV (79% males), 1275 incident cancers were diagnosed. From 1997–2000 to 2016– 2020, we saw a decrease in the incidence of all cancers (1113.9 [95% CI 657.7–1765.6] to 683.5 [95% CI 613.4–759.4] per 100 000 person-years), ADCs (403.1 [95% CI 194.2–739.0] to 103.8 [95% CI 79.2–133.6] per 100 000 person-years) and infection-related NADCs (196.6 [95% CI 37.9–591.9] to 121.9 [95% CI 94.3–154.9] per 100 000 person-years). The incidence of infection-unrelated cancers was stable at 451.0 per 100 000 person-years (95% CI 410.3–494.7). The incidence of cancer among females increased over time but was similar to that of males in 2016–2020. Interpretation: Over a 24-year period, the incidence of cancer decreased overall, largely driven by a considerable decrease in the incidence of ADC, whereas the incidence of infection-unrelated cancer remained unchanged and contributed to the greatest burden of cancer. These findings could reflect combination ART–mediated changes in infectious comorbidity and increased life expectancy; targeted cancer screening and prevention strategies are needed.Keywords
This publication has 40 references indexed in Scilit:
- Epidemiologic contributions to recent cancer trends among HIV-infected people in the United StatesAIDS, 2014
- The end of AIDS: HIV infection as a chronic diseaseThe Lancet, 2013
- Comparisons of Health Care Systems in the United States, Germany and CanadaMateria Socio Medica, 2012
- Validation of Case-Finding Algorithms Derived from Administrative Data for Identifying Adults Living with Human Immunodeficiency Virus InfectionPLOS ONE, 2011
- Cancer Burden in the HIV-Infected Population in the United StatesJNCI: Journal of the National Cancer Institute, 2011
- A Meta-Analysis of the Incidence of Non-AIDS Cancers in HIV-Infected IndividualsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2009
- Using the Standardized Difference to Compare the Prevalence of a Binary Variable Between Two Groups in Observational ResearchCommunications in Statistics - Simulation and Computation, 2009
- A review of human carcinogens—Part B: biological agentsThe Lancet Oncology, 2009
- AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy eraCurrent Opinion in Oncology, 2007
- International rules for multiple primary cancers (ICD-0 third edition)European Journal Of Cancer Prevention, 2005